WASHINGTON (AP)– U.S. health regulators are informing five drugmakers to recall their variations of an extensively utilized diabetes medication after laboratory tests discovered raised levels of a pollutant connected to cancer.
The Fda stated late Thursday that a number of batches of the drug metformin evaluated positive for unsafe levels of N-Nitrosodimethylamine, a possible cancer-causing chemical that can form as a production byproduct. The agency has actually stepped up testing after the chemical was found in dozens of shipments of high blood pressure and heartburn drugs last year, setting off recalls of Zantac and other popular non-prescription and prescription medications.
Metformin tablets are a staple of diabetes care, reducing excess sugar